scholarly journals 652 – Clinical Outcomes in Australian Children with Cystic Fibrosis Liver Disease: A Nationwide Retrospective Review with Matched Controls

2019 ◽  
Vol 156 (6) ◽  
pp. S-136-S-137
Author(s):  
Harveen Singh ◽  
Michael J. Coffey ◽  
Chee Yee Ooi
1999 ◽  
Vol 81 (2) ◽  
pp. 125-128 ◽  
Author(s):  
R. Shapira ◽  
N. Hadzic ◽  
R. Francavilla ◽  
G. Koukulis ◽  
J. F Price ◽  
...  

Lung ◽  
2021 ◽  
Vol 199 (2) ◽  
pp. 213-222
Author(s):  
Wicharn Boonjindasup ◽  
Anne B. Chang ◽  
Julie M. Marchant ◽  
J. Yoon Irons ◽  
Margaret S. McElrea

2014 ◽  
Vol 25 (3) ◽  
pp. 159-162 ◽  
Author(s):  
Clara Tan-Tam ◽  
Pamela Liao ◽  
Julio S Montaner ◽  
Mark W Hull ◽  
Charles H Scudamore ◽  
...  

BACKGROUND: The demand for definitive management of end-stage organ disease in HIV-infected Canadians is growing. Until recently, despite international evidence of good clinical outcomes, HIV-infected Canadians with end-stage liver disease were ineligible for transplantation, except in British Columbia (BC), where the liver transplant program of BC Transplant has accepted these patients for referral, assessment, listing and provision of liver allograft. There is a need to evaluate the experience in BC to determine the issues surrounding liver transplantation in HIV-infected patients.METHODS: The present study was a chart review of 28 HIV-infected patients who were referred to BC Transplant for liver transplantation between 2004 and 2013. Data regarding HIV and liver disease status, initial transplant assessment and clinical outcomes were collected.RESULTS: Most patients were BC residents and were assessed by the multidisciplinary team at the BC clinic. The majority had undetectable HIV viral loads, were receiving antiretroviral treatments and were infected with hepatitis C virus (n=16). The most common comorbidities were anxiety and mood disorders (n=4), and hemophilia (n=4). Of the patients eligible for transplantation, four were transplanted for autoimmune hepatitis (5.67 years post-transplant), nonalcoholic steatohepatitis (2.33 years), hepatitis C virus (2.25 years) and hepatitis B-delta virus coinfection (recent transplant). One patient died from acute renal failure while waiting for transplantation. Ten patients died during preassessment and 10 were unsuitable transplant candidates. The most common reason for unsuitability was stable disease not requiring transplantation (n=4).CONCLUSIONS: To date, interdisciplinary care and careful selection of patients have resulted in successful outcomes including the longest living HIV-infected post-liver transplant recipient in Canada.


2002 ◽  
Vol 70 (5) ◽  
pp. 2715-2720 ◽  
Author(s):  
Karen K. Chu ◽  
Donald J. Davidson ◽  
T. Keith Halsey ◽  
Jacqueline W. Chung ◽  
David P. Speert

ABSTRACT Cystic fibrosis patients infected with strains from different genomovars of the Burkholderia cepacia complex can experience diverse clinical outcomes. To identify genomovar-specific determinants that might be responsible for these differences, we developed a pulmonary model of infection in BALB/c mice. Mice were rendered leukopenic by administration of cyclophosphamide prior to intranasal challenge with 1.6 × 104 bacteria. Five of six genomovar II strains persisted at stable numbers in the lungs until day 16 with minimal toxicity, whereas zero of seven genomovar III strains persisted but resulted in variable toxicity. We have developed a chronic pulmonary model of B. cepacia infection which reveals differences among genomovars in terms of clinical infection outcome.


2021 ◽  
Vol 20 ◽  
pp. S59-S60
Author(s):  
A. Mocic Pavic ◽  
M. Masic ◽  
I. Trivic ◽  
S. Sila ◽  
T. Niseteo ◽  
...  

2011 ◽  
Vol 31 (7) ◽  
pp. 1603-1610 ◽  
Author(s):  
A. Burkett ◽  
K. L. Vandemheen ◽  
T. Giesbrecht-Lewis ◽  
K. Ramotar ◽  
W. Ferris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document